2-bromo-3-chloro-6-[(1R)-1-piperazin-1-ylprop-2-enyl]phenol;dihydrochloride
C13H18BrCl3N2O — CID 171300759
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-bromo-3-chloro-6-[(1R)-1-piperazin-1-ylprop-2-enyl]phenol;dihydrochloride
2-bromo-3-chloro-6-[(1R)-1-piperazin-1-ylprop-2-enyl]phenol;dihydrochloride (PubChem CID 171300759) has the molecular formula C13H18BrCl3N2O and a molecular weight of 404.56 g/mol. Its IUPAC name is 2-bromo-3-chloro-6-[(1R)-1-piperazin-1-ylprop-2-enyl]phenol;dihydrochloride.
Molecular Properties
| Compound Name | 2-bromo-3-chloro-6-[(1R)-1-piperazin-1-ylprop-2-enyl]phenol;dihydrochloride |
|---|---|
| PubChem CID | 171300759 |
| Molecular Formula | C13H18BrCl3N2O |
| Molecular Weight | 404.56 g/mol |
| Exact Mass | 401.97 |
| IUPAC Name | 2-bromo-3-chloro-6-[(1R)-1-piperazin-1-ylprop-2-enyl]phenol;dihydrochloride |
| SMILES | C=C[C@H](c1ccc(Cl)c(Br)c1O)N1CCNCC1.Cl.Cl |
| InChI | InChI=1S/C13H16BrClN2O.2ClH/c1-2-11(17-7-5-16-6-8-17)9-3-4-10(15)12(14)13(9)18;;/h2-4,11,16,18H,1,5-8H2;2*1H/t11-;;/m1../s1 |
| InChIKey | KTWWHQBPQQKFGQ-NVJADKKVSA-N |
| XLogP | 3.78 |
| TPSA | 35.50 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 404.56 |
| LogP ≤ 5 | 3.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171300759 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.